About this Research Topic
In the domain of virology, RNA and DNA viruses represent critical areas of study due to their profound impact on global public health, including involvement in both common and severe disease states. These viruses employ complex strategies to interact with host cellular mechanisms, making them central not only to disease progression but also to therapeutic innovations, such as cancer treatments and vaccine development. Despite advances in our understanding, the dynamic interplay between these viruses and host responses reveals persistent knowledge gaps, particularly in the mechanisms of immune evasion and manipulation of cellular processes.
This Research Topic seeks to advance our understanding of virus-host interactions by exploring the molecular bioscience underlying immune responses and viral behavioral patterns. The objective is to gather cutting-edge research that provides new insights into the mechanisms by with RNA and DNA interact with their host.. By doing so, we aim to shed light on pathways that could lead to novel therapeutic strategies and enhance the efficacy of existing treatments.
We encourage submissions focusing on a wide spectrum of relevant issues, including but not limited to:
o The cellular entry, replication, and assembly processes of RNA and DNA viruses.
o The role of host cell factors in the viral life cycles.Strategies RNA and DNA viruses use to evade host immunity.
o Host immune responses to viral infections.Development of antiviral agents that disrupt virus-host interplays.
o Applications of DNA viruses in vaccine and cancer therapy development.
Innovations in high-throughput sequencing, CRISPR-Cas, and other technologies to further our understanding of virus-host dynamics.
Note that Dr Zhenlong Liu has a CO-PI research position at Lady Davis Institute, McGill University. He is also CEO & cofounder of Ebovir Biotechnologie Inc, which is not related to this research topic.
This Research Topic seeks to advance our understanding of virus-host interactions by exploring the molecular bioscience underlying immune responses and viral behavioral patterns. The objective is to gather cutting-edge research that provides new insights into the mechanisms by with RNA and DNA interact with their host.. By doing so, we aim to shed light on pathways that could lead to novel therapeutic strategies and enhance the efficacy of existing treatments.
We encourage submissions focusing on a wide spectrum of relevant issues, including but not limited to:
o The cellular entry, replication, and assembly processes of RNA and DNA viruses.
o The role of host cell factors in the viral life cycles.Strategies RNA and DNA viruses use to evade host immunity.
o Host immune responses to viral infections.Development of antiviral agents that disrupt virus-host interplays.
o Applications of DNA viruses in vaccine and cancer therapy development.
Innovations in high-throughput sequencing, CRISPR-Cas, and other technologies to further our understanding of virus-host dynamics.
Note that Dr Zhenlong Liu has a CO-PI research position at Lady Davis Institute, McGill University. He is also CEO & cofounder of Ebovir Biotechnologie Inc, which is not related to this research topic.
Keywords: RNA viruses, Host-pathogen interactions, Immune evasion, Antiviral therapies, Virus-host interactions, DNA viruses
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
